Sending Office: Honorable Debbie Wasserman Schultz
FY20 Appropriations Letter: Fund Psoriasis Research
Support Psoriasis Disease Initiative at CDC
Deadline: March 22
Please join me in requesting $1 million in funding, as well as corresponding report language, to advance public health initiatives at the Centers for Disease Control and Prevention (CDC) to improve the lives of people who are impacted by psoriasis and psoriatic
More than eight million Americans live with psoriasis and psoriatic arthritis, diseases that may cause chronic pain and disfigurement. Many of those suffering from psoriasis may also develop psoriatic arthritis, an inflammatory form of arthritis that may
cause irreversible joint damage. Guidelines from the American Academy of Dermatology and National Psoriasis Foundation found that those suffering from the disease are at a higher risk of developing comorbid conditions including cardiovascular disease and stroke,
diabetes and hypertension, as well as depression and anxiety.
In 2010, CDC worked with experts in psoriasis, psoriatic arthritis, and public health to develop an agenda titled Developing and Addressing the Public
Health Agenda for Psoriasis and Psoriatic Arthritis (Agenda). The results of the report have helped inform current knowledge, needs, and gaps for key issues related to psoriasis. While the work of CDC has been promising, the agency has not obtained
follow-on funding to pursue the priorities laid out in this agenda. Targeted funding, including report language that would direct CDC to study the connection between psoriasis and other chronic conditions, would help CDC develop better public health interventions
for those suffering from psoriasis and other immune-mediated diseases.
Debbie Wasserman Schultz
Member of Congress